|
NCT00002347
|
Phase 2
|
The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection
|
N/A
|
|
NCT00002348
|
Phase 2
|
A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma
|
N/A
|
|
NCT00002349
|
Not Applicable
|
A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
|
N/A
|
|
NCT00002350
|
Phase 1
|
A Phase I Trial of APL 400-003 Vaccine: Safety and Immune Response Evaluations of Multiple Injections at Escalating Doses in Asymptomatic HIV-Infected Patients
|
N/A
|
|
NCT00002351
|
Phase 1
|
A Study of L-735,524 in HIV-Positive Children and Adolescents
|
N/A
|
|
NCT00002352
|
Not Applicable
|
A Study of Lobucavir in Patients With AIDS
|
N/A
|
|
NCT00002353
|
Phase 1
|
A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Immunotherapeutic P3C541b in HIV-1 Seropositive Human Subjects
|
N/A
|
|
NCT00002354
|
Not Applicable
|
A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients
|
N/A
|
|
NCT00002355
|
Not Applicable
|
A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes
|
N/A
|
|
NCT00002356
|
Phase 2
|
The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes
|
N/A
|
|
NCT00002357
|
Phase 2
|
The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
|
N/A
|
|
NCT00002358
|
Phase 3
|
A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZV
|
N/A
|
|
NCT00002359
|
Phase 3
|
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
|
N/A
|
|
NCT00002360
|
Phase 1
|
A Study Comparing Two Forms of Didanosine in HIV-infected Patients
|
N/A
|
|
NCT00002361
|
Phase 2
|
Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors
|
N/A
|
|
NCT00002362
|
Phase 3
|
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
|
N/A
|
|
NCT00002363
|
Phase 1
|
The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients
|
N/A
|
|
NCT00002364
|
Phase 2
|
A Study of 1592U89 Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs
|
N/A
|
|
NCT00002365
|
Phase 1
|
A Study of LXR015-1 in HIV-Infected Patients
|
N/A
|
|
NCT00002366
|
Phase 2
|
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
|
N/A
|